Have a personal or library account? Click to login
Antitumor Activity of Palladium(II) Complexes on DU-145 Cell Line In vitro Cover

Antitumor Activity of Palladium(II) Complexes on DU-145 Cell Line In vitro

Open Access
|Dec 2025

Figures & Tables

Figure 1.

The effects of Pd(II) complexes (C1-C5) and ligands (L1-L5) on the viability of human prostate cancer cells DU-145.
The effects of Pd(II) complexes (C1-C5) and ligands (L1-L5) on the viability of human prostate cancer cells DU-145.

Figure 2.

Pd(II) complexes (C1-C5) reduce the viability of treated DU-145 cells predominantly by induction of apoptosis
Pd(II) complexes (C1-C5) reduce the viability of treated DU-145 cells predominantly by induction of apoptosis

Figure 3.

Pd(II) complexes (C2-C5) induce cell cycle arrest of treated DU-145 cells.
Pd(II) complexes (C2-C5) induce cell cycle arrest of treated DU-145 cells.

Figure 4.

Pd(II) complexes C1-C5 induce apoptosis of human prostate cancer cells DU-145 via the mitochondrial pathway.
Pd(II) complexes C1-C5 induce apoptosis of human prostate cancer cells DU-145 via the mitochondrial pathway.

IC50 values for ligands L1-L5, Pd(II) complexes C1-C5 and cisplatin after 24, 48, and 72h drug exposure_

IC50 (μM)DU-145
24h48h72h

L1>200>200>200
L2>200>200>200
L3>200>200>200
L4>200>200>200
L5>200>200>200
C182,950,341,7
C298,747,826,21
C360,844,736,5
C4134,959,147,6
C5111,855,138,9
cisplatin134,557,249,2
DOI: https://doi.org/10.2478/sjecr-2022-0003 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 145 - 152
Submitted on: Jan 10, 2022
|
Accepted on: Jan 21, 2022
|
Published on: Dec 31, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Dejan Simic, Milan Zaric, Stefan Jakovljevic, Katarina Pantic, Djordje Petrovic, Sandra Jovicic Milic, Petar Canovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.